Mikhail Sumin
Ingelheim Am Rhein, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Proteomic patterns according to ejection fraction: an EMPEROR-programme analysis.
Journal: European journal of heart failure
Published: July 24, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program.
Journal: European journal of heart failure
Published: April 17, 2025
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program.
Journal: Journal of the American College of Cardiology
Published: January 09, 2025
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction.
Journal: Nature cardiovascular research
Published: August 27, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.
Journal: European journal of heart failure
Published: July 19, 2024
Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program.
Journal: Journal of the American College of Cardiology
Published: June 10, 2024
Empagliflozin after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
Journal: Journal of the American College of Cardiology
Published: February 22, 2024
Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.
Journal: European journal of heart failure
Published: November 05, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
Journal: European journal of heart failure
Published: September 20, 2023
Last Updated: 09/26/2026